 The National Institutes of Health partnered with biotech company Moderna to create a safe and efficacious COVID-19 vaccine and is also at the forefront of developing critical antibody treatments and therapeutics. While the first round of vaccinations commences in the U.S., NIH director Francis Collins, MD, will join TheWashington Post’s Frances Stead Sellers for the latest updates on coronavirus treatment, the country’s historic mass inoculation campaign, and how public health officials are combating skepticism and educating the public about vaccines. Join the conversation onWednesday, Jan. 6 at 10:00 a.m. ET.
Stream here: wapo.st/collins
Â